104 related articles for article (PubMed ID: 7890253)
21. A randomized study to compare the effectiveness, tolerability, and acceptability of two different transdermal estradiol replacement therapies. The Transdermal HRT Investigators Group.
Int J Fertil Menopausal Stud; 1993; 38(1):5-11. PubMed ID: 8485612
[TBL] [Abstract][Full Text] [Related]
22. Gonadotropin dynamics in women receiving immediate or delayed transdermal estradiol after oophorectomy.
Kamel EM; Maurer SA; Hochler MG; Hoffman DI; Rebar RW
Obstet Gynecol; 1991 Jul; 78(1):98-102. PubMed ID: 1904568
[TBL] [Abstract][Full Text] [Related]
23. Effects of vehicle supplementation on total estradiol absorption from a transdermal estradiol delivery system.
Smith RD; Robinson DE; Delignieres B; Albertson BD; Tomai TP; Zinaman MJ; Simon JA
Fertil Steril; 1991 Dec; 56(6):1029-33. PubMed ID: 1743317
[TBL] [Abstract][Full Text] [Related]
24. Acute ethanol intoxication does not influence gonadotropin secretion in postmenopausal women.
Välimäki M; Pelkonen R; Ylikahri R
Alcohol Alcohol; 1987; 22(2):143-6. PubMed ID: 3115276
[TBL] [Abstract][Full Text] [Related]
25. Sexually and well-being in early menopause. Effect of transdermal estradiol therapy.
Rigano A; Rigano M; Cancellieri F; Pullè C
Panminerva Med; 2001 Jun; 43(2):115-8. PubMed ID: 11449182
[TBL] [Abstract][Full Text] [Related]
26. The effect of estradiol and a combined estradiol/progestagen preparation on insulin sensitivity in healthy postmenopausal women.
Duncan AC; Lyall H; Roberts RN; Petrie JR; Perera MJ; Monaghan S; Hart DM; Connell JM; Lumsden MA
J Clin Endocrinol Metab; 1999 Jul; 84(7):2402-7. PubMed ID: 10404811
[TBL] [Abstract][Full Text] [Related]
27. Nanoparticle delivery for transdermal HRT.
Valenzuela P; Simon JA
Nanomedicine; 2012 Sep; 8 Suppl 1():S83-9. PubMed ID: 22640909
[TBL] [Abstract][Full Text] [Related]
28. [Hormone replacement therapy with a transdermal estradiol gel and oral micronized progesterone. Effect on menopausal symptoms and lipid metabolism].
Giuliani A; Concin H; Wieser F; Boritsch J; Wilfert H; Gruber D; Urdl W
Wien Klin Wochenschr; 2000 Jul; 112(14):629-33. PubMed ID: 11008325
[TBL] [Abstract][Full Text] [Related]
29. Estradiol gel: review of the pharmacology, pharmacokinetics, efficacy, and safety in menopausal women.
Naunton M; Al Hadithy AF; Brouwers JR; Archer DF
Menopause; 2006; 13(3):517-27. PubMed ID: 16735950
[TBL] [Abstract][Full Text] [Related]
30. Hormonal replacement therapy in menopausal women with a history of hyperprolactinemia.
Touraine P; Deneux C; Plu-Bureau G; Mauvais-Jarvis P; Kuttenn F
J Endocrinol Invest; 1998 Dec; 21(11):732-6. PubMed ID: 9972671
[TBL] [Abstract][Full Text] [Related]
31. [Bioavailability of 17 beta-estradiol after transdermal administration--dependence on the patch system].
Schmolling J; Kusche J; van der Ven H; Schander K
Zentralbl Gynakol; 1998; 120(3):121-5. PubMed ID: 9556902
[TBL] [Abstract][Full Text] [Related]
32. Estrogen augments serotonergic activity in postmenopausal women.
Halbreich U; Rojansky N; Palter S; Tworek H; Hissin P; Wang K
Biol Psychiatry; 1995 Apr; 37(7):434-41. PubMed ID: 7786956
[TBL] [Abstract][Full Text] [Related]
33. A randomized, controlled trial of estradiol replacement therapy in women with hypergonadotropic amenorrhea.
Taylor AE; Adams JM; Mulder JE; Martin KA; Sluss PM; Crowley WF
J Clin Endocrinol Metab; 1996 Oct; 81(10):3615-21. PubMed ID: 8855811
[TBL] [Abstract][Full Text] [Related]
34. Comparison of transdermal to oral estradiol administration on hormonal and hepatic parameters in women with premature ovarian failure.
Steingold KA; Matt DW; DeZiegler D; Sealey JE; Fratkin M; Reznikov S
J Clin Endocrinol Metab; 1991 Aug; 73(2):275-80. PubMed ID: 1906893
[TBL] [Abstract][Full Text] [Related]
35. Comparison of efficacy and local tolerability of estradiol metered-dose transdermal spray to estradiol patch in a network meta-analysis.
Kovács G; Zelei T; Vokó Z
Climacteric; 2016 Oct; 19(5):488-95. PubMed ID: 27593417
[TBL] [Abstract][Full Text] [Related]
36. Effect of acute ethanol ingestion on integrated plasma prolactin levels in normal men.
Ellingboe J; Mendelson JH; Kuehnle JC; Skupny AS; Miller KD
Pharmacol Biochem Behav; 1980 Feb; 12(2):297-301. PubMed ID: 7375492
[TBL] [Abstract][Full Text] [Related]
37. Testosterone treatment of HSDD in naturally menopausal women: the ADORE study.
Panay N; Al-Azzawi F; Bouchard C; Davis SR; Eden J; Lodhi I; Rees M; Rodenberg CA; Rymer J; Schwenkhagen A; Sturdee DW
Climacteric; 2010 Apr; 13(2):121-31. PubMed ID: 20166859
[TBL] [Abstract][Full Text] [Related]
38. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
Reyes FI; Winter JS; Faiman C
Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
[TBL] [Abstract][Full Text] [Related]
39. Effects of hormone-replacement therapy on fibrinolysis in postmenopausal women.
Koh KK; Mincemoyer R; Bui MN; Csako G; Pucino F; Guetta V; Waclawiw M; Cannon RO
N Engl J Med; 1997 Mar; 336(10):683-90. PubMed ID: 9041098
[TBL] [Abstract][Full Text] [Related]
40. Transdermal menopausal hormone therapy: delivery through skin changes the rules.
Buster JE
Expert Opin Pharmacother; 2010 Jun; 11(9):1489-99. PubMed ID: 20426703
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
